Russell Investments Group, Ltd. Co Diagnostics, Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$5.03 - $9.61 $1.22 Million - $2.33 Million	-242,232 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$8.12 - $10.37 $738,708 - $943,400	-90,974 Reduced 27.3%	242,232 $2.16 Million
Q3 2021 Nov 08, 2021	BUY	$7.48 - $11.38 $593,081 - $902,308	79,289 Added 31.23%	333,206 $3.24 Million
Q2 2021 Aug 04, 2021	BUY	$7.16 - $9.56 $588,458 - $785,707	82,187 Added 47.86%	253,917 $2.09 Million
Q1 2021 May 10, 2021	BUY	$8.52 - $19.21 $1.46 Million - $3.3 Million	171,730 New	171,730 $1.64 Million

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.